Lipid nanoparticle (LNP) packaged mRNA vaccines have been deployed against infectious diseases such as COVID-19, yet their structural features remain unclear. Cholesterol, a major constituent within ...LNPs, contributes to their morphology that influences gene delivery. Herein, we examine the structure of LNPs containing cholesterol derivatives using electron microscopy, differential scanning calorimetry, and membrane fluidity assays. LNPs formulated with C24 alkyl derivatives of cholesterol show a polymorphic shape and various degrees of multilamellarity and lipid partitioning, likely due to phase separation. The addition of methyl and ethyl groups to the C24 alkyl tail of the cholesterol backbone induces multilamellarity (>50% increase compared to cholesterol), while the addition of a double bond induces lipid partitioning (>90% increase compared to cholesterol). LNPs with multilamellar and faceted structures, as well as a lamellar lipid phase, showed higher gene transfection. Unraveling the structure of mRNA-LNPs can enable their rational design toward enhanced gene delivery.
Self-assembled mRNA vaccines Kim, Jeonghwan; Eygeris, Yulia; Gupta, Mohit ...
Advanced drug delivery reviews,
03/2021, Letnik:
170
Journal Article
Recenzirano
Odprti dostop
mRNA vaccines have evolved from being a mere curiosity to emerging as COVID-19 vaccine front-runners. Recent advancements in the field of RNA technology, vaccinology, and nanotechnology have ...generated interest in delivering safe and effective mRNA therapeutics. In this review, we discuss design and self-assembly of mRNA vaccines. Self-assembly, a spontaneous organization of individual molecules, allows for design of nanoparticles with customizable properties. We highlight the materials commonly utilized to deliver mRNA, their physicochemical characteristics, and other relevant considerations, such as mRNA optimization, routes of administration, cellular fate, and immune activation, that are important for successful mRNA vaccination. We also examine the COVID-19 mRNA vaccines currently in clinical trials. mRNA vaccines are ready for the clinic, showing tremendous promise in the COVID-19 vaccine race, and have pushed the boundaries of gene therapy.
Display omitted
•mRNA vaccines showed spectacular success in the race for COVID-19 vaccines.•Design of both mRNA and the delivery vectors help in fine-tuning efficacy.•Self-assembled mRNA delivery vectors include lipid and polymer nanoparticles.•Lipid nanoparticle mRNA vaccines have ca. 95% efficacy and earned EUA FDA approval.•These unprecedented results may pave the road for future mRNA vaccine development.
We have prepared novel pH-responsive nanoporous membranes by the self-assembly of silica nanoparticles carrying poly(2-(dimethylamino)ethyl methacrylate) (PDMAEMA) brushes with a degree of ...polymerization (DP) in the 100–450 range. The nanoparticles were prepared by surface-initiated ARGET-ATRP, and the membranes were assembled by pressure-driven deposition onto porous supports. The permeability and pore size of the resulting robust membranes were studied using water and hexane flux and filtration cutoff experiments. The pore size of the PDMAEMA “hairy” silica nanoparticle (HNP) membranes measured by water flux was ca. 22 nm and was mostly independent of the polymer brush length. We attributed this to a combination of the PDMAEMA brushes swelling and their permeability to water. In contrast, the pore size measured by hexane flux strongly depended on the DP. The flux and pore size of these membranes in water strongly depended on the pH. The pore size decreased by a factor of 1.6 when the pH was changed from neutral to acidic. pH-Responsive HNP membranes combine many attractive properties, including control over the filtration cutoff, responsive permeability, and high flux at low pressure. The reversible self-assembly of the PDMAEMA HNP membranes may help not only in their facile preparation but also in material recycling if biofouling occurs. The key features of the PDMAEMA HNP assemblies are attractive in membrane separations, molecular valves, and biosensors, where having precise control over the pore size and pore gating is highly desirable.
Lipid-based nanoparticles (LNPs) for the delivery of mRNA have jumped to the forefront of non-viral gene delivery. Despite this exciting development, poor endosomal escape after LNP cell entry ...remains an unsolved, rate-limiting bottleneck. Here we report the use of a galectin 8-GFP (Gal8-GFP) cell reporter system to visualize the endosomal escape capabilities of LNP-encapsulated mRNA. LNPs substituted with phytosterols in place of cholesterol exhibited various levels of Gal8 recruitment in the Gal8-GFP reporter system. In live-cell imaging, LNPs containing β-sitosterol (LNP-Sito) showed a 10-fold increase in detectable endosomal perturbation events when compared to the standard cholesterol LNPs (LNP-Chol), suggesting the superior capability of LNP-Sito to escape from endosomal entrapment. Trafficking studies of these LNPs showed strong localization with late endosomes. This highly sensitive and robust Gal8-GFP reporter system can be a valuable tool to elucidate intricacies of LNP trafficking and ephemeral endosomal escape events, enabling advancements in gene delivery.
Despite lipid nanoparticles’ (LNPs) success in the effective and safe delivery of mRNA vaccines, an inhalation-based mRNA therapy for lung diseases remains challenging. LNPs tend to disintegrate due ...to shear stress during aerosolization, leading to ineffective delivery. Therefore, LNPs need to remain stable through the process of nebulization and mucus penetration, yet labile enough for endosomal escape. To meet these opposing needs, we utilized PEG lipid to enhance the surficial stability of LNPs with the inclusion of a cholesterol analog, β-sitosterol, to improve endosomal escape. Increased PEG concentrations in LNPs enhanced the shear resistance and mucus penetration, while β-sitosterol provided LNPs with a polyhedral shape, facilitating endosomal escape. The optimized LNPs exhibited a uniform particle distribution, a polyhedral morphology, and a rapid mucosal diffusion with enhanced gene transfection. Inhaled LNPs led to localized protein production in the mouse lung without pulmonary or systemic toxicity. Repeated administration of these LNPs led to sustained protein production in the lungs. Lastly, mRNA encoding the cystic fibrosis transmembrane conductance regulator (CFTR) was delivered after nebulization to a CFTR-deficient animal model, resulting in the pulmonary expression of this therapeutic protein. This study demonstrated the rational design approach for clinical translation of inhalable LNP-based mRNA therapies.
In recent years, nanoparticles have evolved to a clinical modality to deliver diverse nucleic acids. Rising interest in nanomedicines comes from proven safety and efficacy profiles established by ...continuous efforts to optimize physicochemical properties and endosomal escape. However, despite their transformative impact on the pharmaceutical industry, the clinical use of non-viral nucleic acid delivery is limited to hepatic diseases and vaccines due to liver accumulation. Overcoming liver tropism of nanoparticles is vital to meet clinical needs in other organs. Understanding the anatomical structure and physiological features of various organs would help to identify potential strategies for fine-tuning nanoparticle characteristics. In this Review, we discuss the source of liver tropism of non-viral vectors, present a brief overview of biological structure, processes and barriers in select organs, highlight approaches available to reach non-liver targets, and discuss techniques to accelerate the discovery of non-hepatic therapies.
Lipid nanoparticles containing messenger RNA (mRNA-LNPs) have launched to the forefront of nonviral delivery systems with their realized potential during the COVID-19 pandemic. Here, we investigate ...the impact of commonly used biological buffers on the performance and durability of mRNA-LNPs. We tested the compatibility of three common buffersHEPES, Tris, and phosphate-buffered salinewith a DLin-MC3-DMA mRNA-LNP formulation before and after a single controlled freeze–thaw cycle. We hypothesized that buffer composition would affect lipid-aqueous phase separation. Indeed, the buffers imposed structural changes in LNP morphology as indicated by electron microscopy, differential scanning calorimetry, and membrane fluidity assays. We employed in vitro and in vivo models to measure mRNA transfection and found that Tris or HEPES-buffered LNPs yielded better cryoprotection and transfection efficiency compared to PBS. Understanding the effects of various buffers on LNP morphology and efficacy provides valuable insights into maintaining the stability of LNPs after long-term storage.
Nanoporous membranes play a critical role in numerous separations on laboratory and industrial scales, ranging from water treatment to biotechnology. However, few strategies exist that allow for the ...preparation of mechanically robust nanoporous membranes whose separation properties can be easily tuned. Here, we introduce a new family of tunable nanoporous membranes based on nanoparticles decorated with temperature-responsive polymer brushes. We prepared mechanically robust membranes from hairy nanoparticles (HNPs) carrying PNIPAM polymer brushes. We assembled the HNPs into thin films through pressure-driven deposition of nanoparticle suspensions and measured the permeability and filtration cutoff of these membranes at different temperatures. The membrane pore diameter at room temperature varied between 10 and 30 nm depending on the polymer length. The water permeability of these membranes could be controlled by temperature, with the effective pore diameter increasing by a factor of 3–6 (up to 100 nm) when the temperature was increased to 60 °C. The size selectivity of these membranes in the filtration of nanoparticles could also be attenuated by temperature. Molecular dynamics computer simulations of a coarse-grained HNP model show that temperature-sensitive pores sizes are consistent with our experimental results and reveal the polymer configurations responsible for the observed filtration membrane permeability. We expect that these membranes will be useful for separations and in the preparation of responsive microfluidic devices.
Leveraging the extensive surface area of the lungs for gene therapy, the inhalation route offers distinct advantages for delivery. Clinical nebulizers that employ vibrating mesh technology are the ...standard choice for converting liquid medicines into aerosols. However, they have limitations when it comes to delivering mRNA through inhalation, including severe damage to nanoparticles due to shearing forces. Here, we introduce a microfluidic aerosolization platform (MAP) that preserves the structural and physicochemical integrity of lipid nanoparticles, enabling safe and efficient delivery of mRNA to the respiratory system. Our results demonstrated the superiority of the MAP over the conventional vibrating mesh nebulizer, as it avoided problems such as particle aggregation, loss of mRNA encapsulation, and deformation of the nanoparticle morphology. Notably, aerosolized nanoparticles generated by the microfluidic device led to enhanced transfection efficiency across various cell lines. In vivo experiments with mice that inhaled these aerosolized nanoparticles revealed successful lung-specific mRNA transfection without observable signs of toxicity. This MAP may represent an advancement for the pulmonary gene therapy, enabling precise and effective delivery of aerosolized nanoparticles.
PDF
